Hypidone

Source: Wikipedia, the free encyclopedia.
Hypidone
Clinical data
Other namesYL-0919; YL0919
Identifiers
  • 1-[(1-benzyl-4-hydroxypiperidin-4-yl)methyl]pyridin-2-one
JSmol)
  • C1CN(CCC1(CN2C=CC=CC2=O)O)CC3=CC=CC=C3
  • InChI=1S/C18H22N2O2/c21-17-8-4-5-11-20(17)15-18(22)9-12-19(13-10-18)14-16-6-2-1-3-7-16/h1-8,11,22H,9-10,12-15H2
  • Key:BGMVOROUOUVVRV-UHFFFAOYSA-N

Hypidone (developmental code name YL-0919) is an investigational

full agonist.[1][5] It is used as the hydrochloride salt.[2][5] As of January 2021, hypidone is in phase 2 clinical trials for major depressive disorder.[1]

See also

References

  1. ^ a b c "Hypidone hydrochloride - Shanghai Synergy Pharmaceutical Sciences - AdisInsight". adisinsight.springer.com. Retrieved 2021-10-09.
  2. ^
    PMID 27882537
    .
  3. S2CID 44125
    .
  4. PMID 33324217
    .
  5. ^
    PMID 33643051
    .

External links


Retrieved from "https://en.wikipedia.org/w/index.php?title=Hypidone&oldid=1217439056"